0001209191-22-015593.txt : 20220303 0001209191-22-015593.hdr.sgml : 20220303 20220303170046 ACCESSION NUMBER: 0001209191-22-015593 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220301 FILED AS OF DATE: 20220303 DATE AS OF CHANGE: 20220303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moore Mary Ann E CENTRAL INDEX KEY: 0001894731 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12111 FILM NUMBER: 22710006 MAIL ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDNAX, INC. CENTRAL INDEX KEY: 0000893949 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 263667538 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 BUSINESS PHONE: 9543840175 MAIL ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 FORMER COMPANY: FORMER CONFORMED NAME: PEDIATRIX MEDICAL GROUP INC DATE OF NAME CHANGE: 19950801 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-01 0 0000893949 MEDNAX, INC. MD 0001894731 Moore Mary Ann E 1301 CONCORD TERRACE SUNRISE FL 33323 0 1 0 0 EVP Chief ERM/Legal Ops Off Common Stock 16880 I By Trust Common Stock 2022-03-01 4 A 0 16340 0.00 A 30561 D Common Stock 2022-03-01 4 A 0 16340 0.00 A 46901 D Common Stock 2022-03-01 4 F 0 1525 23.47 D 45376 D The reporting person and her spouse are trustees of the trust that holds the reported securities. The reporting person disclaims beneficial interest of the reported securities except to the extent of her pecuniary interest therein. Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on March 1, 2023, twenty-five percent (25%) of the restricted shares will vest on March 1, 2024 and fifty percent (50%) of the restricted shares will vest on March 1, 2025, subject to the terms of the Plan. Restricted shares granted pursuant to the Plan in connection with an annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 8,170 additional shares based on the achievement of certain performance-based criteria for the twelve months ending December 31, 2022. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three installments of twenty-five percent (25%) on March 1, 2023, twenty-five percent (25%) on March 1, 2024 and fifty percent (50%) on March 1, 2025, subject to the terms of the Plan. Represents 1,525 restricted shares withheld for payment of taxes upon vesting of shares. /s/ Dominic J. Andreano, Attorney-in-Fact 2022-03-03